Liangqiang Li

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Early Breast Cancer

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Journal of breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Liangqiang Li, Jing Yu, Kunwei Shen, Xiaosong Chen
The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients. Journal of breast cancer (2024)
Liangqiang Li, Jing Yu, Kunwei Shen, Xiaosong Chen
The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients. Journal of breast cancer 27 (3) (2024)
Liangqiang Li, Jing Yu, Kunwei Shen, Xiaosong Chen
The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients. Journal of breast cancer 27 (3) (2024)
Liangqiang Li, Jing Yu, Kunwei Shen, Xiaosong Chen
The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients. Journal of breast cancer 27 (3) (2024)